Comparison of percutaneous nephrostomy versus DJ stent in early normalization of renal function test in obstructive uropathy secondary to urolithiasis

Authors

  • Muhammad Idrees Hanif Sindh Institute of Urology and Transplantation, Karachi Pakistan
  • Hafiz Dur-e-Furqani Sindh Institute of Urology and Transplantation, Karachi Pakistan
  • Rashid Zia Sindh Institute of Urology and Transplantation, Karachi Pakistan
  • Amr Abdullah Ahmed Shaddad Sindh Institute of Urology and Transplantation, Karachi Pakistan
  • Abdul Rehman Sindh Institute of Urology and Transplantation, Karachi Pakistan
  • Syed Rafiuddin Shah Sindh Institute of Urology and Transplantation, Karachi Pakistan`

DOI:

https://doi.org/10.55629/pakjpathol.v36i3.922

Abstract

Objective: To compare the pathological and clinical outcomes of percutaneous nephrostomy (PCN) versus double-J (DJ) stent placement in restoring renal function in obstructive uropathy secondary to urolithiasis, focusing on mechanisms of tubular injury, fibrosis, and inflammatory response.

Material and Methods: A randomized clinical trial (March–September 2023) included 200 patients (100 PCN, 100 DJ stent) with obstructive uropathy due to urolithiasis. Inclusion criteria: age 18–75 years, elevated serum creatinine (>1.03 mg/dL males; >1.1 mg/dL females), and urea (>20 mg/dL). Renal function normalization time (hours) was measured post-intervention. Quantitative variables (age, stone size/duration, BMI) were analyzed using independent t-test/Mann-Whitney U test. Pathological correlates included TGF-β-mediated fibrosis, angiotensin II activity, and mononuclear leukocyte infiltration.

Results: PCN demonstrated significantly faster renal recovery (100.20 (15.41) hours vs. DJ stent: 109.40 (15.15) hours, p=0.001). Stratified analysis revealed prolonged obstruction (>10 days) exacerbated interstitial fibrosis in DJ stent patients (117.29 (7.67) hours vs. PCN: 108.14 (7.75) hours, p=0.001). Diabetic patients exhibited delayed normalization (PCN: 106.17 (6.52) hours; DJ: 117.00 (8.25) hours, p=0.001), correlating with heightened oxidative stress.

Conclusion: PCN accelerates renal function recovery by mitigating pathological cascades (ischemia, TGF-β-driven fibrosis, and cytokine release) more effectively than DJ stents. These findings highlight the role of rapid decompression in reducing chronic tubulointerstitial damage.

Keywords:  Inflammatory cytokines, Obstructive uropathy, Percutaneous nephrostomy, Renal ischemia, Tubulointerstitial fibrosis, Urolithiasis.

References

Türk C, Petřík A, Sarica K, Seitz C, Skolarikos A, Straub M, et al. EAU guidelines on diagnosis and conservative management of urolithiasis. Eur Urol. 2016; 69(3): 468-74. DOI: https://doi.org/10.1016/j.eururo.2015.07.040

Saeed K, Hussain SA, Kanjoo SR, Ahmad B, Hussain M. Double-J stenting versus percutaneous nephrostomy. Ann Punjab Med Coll. 2020; 14(4): 336-9. DOI: https://doi.org/10.29054/apmc/2020.1108

Yaxley J, Yaxley W. Obstructive uropathy - acute and chronic medical management. World J Nephrol. 2023;12(1):1-9. doi:10.5527/wjn.v12.i1.1

Nørregaard R, Mutsaers HA, Frøkiær J, Kwon TH. Obstructive nephropathy and molecular pathophysiology of renal interstitial fibrosis. Physiol Rev. 2023;103(4):2847-2892. DOI: https://doi.org/10.1152/physrev.00027.2022

Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and management. JAMA. 2019; 322(13):1294-304. DOI: https://doi.org/10.1001/jama.2019.14745

Ghasemi-Rad M, Trinh K, Wynne D, Ahmadzade M, Shamim MH, Guerrero O, et al. Nephrostomy (PCN) versus nephroureteral stent (Double JJ); An ongoing battle. Urologia J. 2025; 92(3): 424-431. DOI: https://doi.org/10.1177/03915603251316702

Ali L, Khan S, Khan FH, Orakzai N. Comparison of PCN and DJ stent in renal recovery. Ann PIMS. 2020; 16(1): 10-14.

DOI: https://doi.org/10.48036/apims.v16i1.301

Khan SA, Kumar N, Bux K, Chachar MA, Bangwarah AK. Comparison efficacy between percutaneous nephrostomy and double J stent in management of obstructive uropathy. J Health Rehabil Res. 2024; 4(1): 1339-1342.

DOI: https://doi.org/10.61919/jhrr.v4i1.627

Naeem M, Jan MA, Ullah A, Ali L, Khan S, Haq A, et al. Percutaneous nephrostomy for tHE relief of upper urinary tract obstruction: an experience with 200 cases. J Postgrad Med Inst. 2010; 24(2): 124-9. Available from: https://jpmi.org.pk/index.php/ jpmi/article/view/1056

Misseri R, Rink RC, Meldrum DR, et al. Inflammatory mediators and growth factors in obstructive renal injury. J Surg Res. 2004; 119(2): 149-59. DOI: https://doi.org/10.1016/j.jss.2004.03.003

Truong LD, Gaber L, Eknoyan G. Obstructive uropathy. Contrib Nephrol. 2011; 169: 311-26. DOI: https://doi.org/10.1159/000314578

Sacks SH, Aparicio SA, Bevan A, Oliver OD, Will J, Davidson AM. et al. CKD risk post-obstruction. BMJ. 1989; 298(6667): 156-9. DOI: https://doi.org/10.1136/bmj.298.6667.156

Moon YJ, Jun DY, Jeong JY, Cho S, Lee JY, Jung HD. Percutaneous nephrostomy versus ureteral stent for severe urinary tract infection with obstructive urolithiasis: A systematic review and meta-analysis. Medicina. 2024; 60(6): e861. DOI: https://doi.org/10.3390/medicina60060861

Sutariya B, Jhonsa D, Saraf MN. TGF-β: The connecting link between nephropathy and fibrosis. Immunopharmacol Immunotoxicol. 2016; 38(1): 39-49. DOI:https://doi.org/10.3109/08923973.2015.1127382

Pigatto Filho G, Nichele SA, de Oliveira FV, Santos LS, de Fraga R. Time-sensitive elements in elective treatment of urinary lithiasis: A narrative review. Transl Androl Urol. 2025; 14(1): e181. DOI: https://doi.org/10.21037/tau-24-596

Downloads

Published

30-09-2025

How to Cite

1.
Hanif MI, Dur-e-Furqani H, Zia R, Shaddad AAA, Rehman A, Shah SR. Comparison of percutaneous nephrostomy versus DJ stent in early normalization of renal function test in obstructive uropathy secondary to urolithiasis . Pak J Pathol [Internet]. 2025 Sep. 30 [cited 2026 Nov. 17];36(3):170-5. Available from: https://pakjpath.com/index.php/Pak-J-Pathol/article/view/922